AI-powered chatbots like ChatGPT are poised to revolutionise healthcare by becoming the new 'Dr. Google'. In these two short reports, we outline the perspectives of surveyed HCPs and consumers to uncover how such technology is perceived to be influencing the patient-HCP interaction. Both reports offer a top-level view of support opportunities in this digital space.
With GLP-1s creating increasingly dynamic social conversation, how do you separate the noise from the strategic signal? In this series of modular reports, we use Ipsos Synthesio’s proprietary Signals GenAI tool to decode millions of real-time social media conversations and transforms them into actionable intelligence for brands in the GLP-1 space.
By decoding vast volumes of unstructured conversation and applying the power of generative AI, we transform raw social data into clear, actionable intelligence –while surfacing the authenticity of the voices it represents. Commission topics that matter most to your brand to form essential guides to the conversations shaping your market.
Against the backdrop of increasing healthcare consumerisation, patients and consumers are increasingly acting as the treatment decision makers and paying for medications themselves. This report explores key out‑of‑pocket (OOP) dynamics across 15 markets, comparing behaviours, attitudes and intentions of individuals regarding treatment purchases across weight loss, eyecare, neurology and dermatology.